Avada comes packaged with several shortcode designs to display your recent blog posts. And each style has several meta options that allow you to customize the shortcode; choose number of columns 1-4, number of posts, set a category, show or hide thumbnails, meta, excerpt, excerpt length and more!

Recent News Default Style

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." [...]

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

marzo 18th, 2025|Comentarios desactivados en Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los [...]

Recent News Thumbnails On Side Style

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos [...]

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

marzo 18th, 2025|Comentarios desactivados en Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente [...]

Recent News Date On Side Style

1803, 2025

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

marzo 18th, 2025|Comentarios desactivados en Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: David A Palma, Robert Olson, Stephen Harrow, Stewart [...]

1803, 2025

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian et al. Fuente: [...]

1803, 2025

The Promise of Combining Radiation Therapy With Immunotherapy

marzo 18th, 2025|Comentarios desactivados en The Promise of Combining Radiation Therapy With Immunotherapy

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Justin C. Jagodinsky, Paul M. Harari and Zachary [...]

1803, 2025

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

marzo 18th, 2025|Comentarios desactivados en Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodriguez-Abreu et al. [...]

Use Them In 1-4 Columns

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

marzo 18th, 2025|Comentarios desactivados en Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: David A Palma, Robert Olson, Stephen Harrow, Stewart Gaede et al. Fuente: Lancet 2019; 393: 2051–58. [...]

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian et al. Fuente: Lancet 2019; 393: 2051–58. Standard-of-care systemic therapy with [...]

Many Meta Options Like Excerpt Length, Category, Posts, Columns

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

marzo 18th, 2025|Comentarios desactivados en Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: David A Palma, Robert Olson, Stephen Harrow, Stewart Gaede et al. Fuente: Lancet 2019; 393: 2051–58. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial   [...]

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian et al. Fuente: Lancet 2019; 393: 2051–58. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): [...]

The Promise of Combining Radiation Therapy With Immunotherapy

marzo 18th, 2025|Comentarios desactivados en The Promise of Combining Radiation Therapy With Immunotherapy

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Justin C. Jagodinsky, Paul M. Harari and Zachary S. Morris. Fuente: Int J Radiation Oncol Biol Phys, Vol. 108, No. 1, pp. 6e16, 2020 The Promise of Combining Radiation Therapy With Immunotherapy Descargar

1803, 2025

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

marzo 18th, 2025|Comentarios desactivados en Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: David A Palma, Robert Olson, Stephen Harrow, Stewart Gaede et al. Fuente: Lancet 2019; 393: 2051–58. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial   [...]

1803, 2025

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

marzo 18th, 2025|Comentarios desactivados en Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian et al. Fuente: Lancet 2019; 393: 2051–58. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): [...]

1803, 2025

The Promise of Combining Radiation Therapy With Immunotherapy

marzo 18th, 2025|Comentarios desactivados en The Promise of Combining Radiation Therapy With Immunotherapy

Lectura recomendada por el Lectura recomendada por el Dr. Mauricio Luongo.  Conferencia 2024: “Presente de los tratamientos con Inmunoradioterapia." Autores: Justin C. Jagodinsky, Paul M. Harari and Zachary S. Morris. Fuente: Int J Radiation Oncol Biol Phys, Vol. 108, No. 1, pp. 6e16, 2020 The Promise of Combining Radiation Therapy With Immunotherapy Descargar

Features and Customizations

  • Three awesome designs to choose from
  • Works with all column sizes and unlimited use and posts
  • Set columns, posts, category, thumbnails, title, meta, excerpt & length
  • Perfect for using on any page you need to highlight your blog posts